Product Information
FENOFIBRATE 67 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.0898 per EA under NDC 62135089390. Its NADAC has been published 90 times since Dec 4, 2024.
FDA first approved this application on Jan 31, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
67 mg/1
Manufacturer
Chartwell RX LLCNDC
62135089390
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211407FDA Approved
1/31/2024
TE Code
AB
On Market Since
1/31/2024
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 67 MG CAPSULE has been published 90 times since Dec 4, 2024, and over the history we have for it it has risen 35.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0898 per EA |
|---|---|
| All-time high | $0.0931 (Aug 12, 2026) |
| All-time low | $0.0662 (Dec 4, 2024) |
| 52-week high | $0.0931 |
| 52-week low | $0.0783 |
| Median price | $0.0855 |
| Average price | $0.0844 |
| Largest weekly change | +11.1% (Dec 18, 2024) |
| Weeks tracked | 90 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 67 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 67 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.0898 per EA (NDC 62135089390), effective Aug 19, 2026.
How has the price of FENOFIBRATE 67 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 67 MG CAPSULE has risen 35.7%. It has been tracked across 90 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 67 MG CAPSULE?
Since Dec 4, 2024, the NADAC for FENOFIBRATE 67 MG CAPSULE has ranged from a low of $0.0662 (Dec 4, 2024) to a high of $0.0931 (Aug 12, 2026), with a median of $0.0855 per EA.
Are there cheaper alternatives to FENOFIBRATE 67 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 67 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRATE 67 MG CAPSULE?
FENOFIBRATE 67 MG CAPSULE (NDC 62135089390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.